TITLE

Hepatitis B virus infection among pregnant women in Taiwan: comparison between women born in Taiwan and other southeast countries

AUTHOR(S)

Ching-Chiang Lin; Hsiu-Shu Hsieh; Yu-Jie Huang; Yeou-Lih Huang; Ming-Kun Ku; Hsin-Chia Hung

PUB. DATE

January 2008

SOURCE

BMC Public Health;2008, Vol. 8 Issue 1, p49

SOURCE TYPE

Academic Journal

DOC. TYPE

Article

ABSTRACT

Background: Taiwan's national vaccination program has successfully decreased the prevalence of hepatitis B infection after twenty years of implementation and might be indirectly beneficial to the second generation. In this study, we compared the hepatitis B infection status of two groups: pregnant Taiwanese women and other Southeast Asian women, who because they had immigrated later in life to Taiwan by marriage to a Taiwanese man, had not been exposed to that vaccination program to evaluate the effect of hepatitis vaccination program on women of child-bearing age and further explored the potential impact of immigration on the hepatitis B public health policy in Taiwan. Methods: Data was collected from 10,327 women born in Taiwan and 1,418 women born in other Southeast Asian countries, both groups receiving prenatal examinations at Fooyin University Hospital between 1996 and 2005. The results of serum hepatitis B s-Antigen (HBsAg) and hepatitis B e-Antigen (HBeAg) tests and other demographic data were obtained by medical chart review. Results: The pregnant women from Taiwan had a higher HBsAg positive rate (15.5%) but lower HBeAg(+)/HBsAg(+) ratio (32.1%) than the women from other countries (8.9% and 52.4%). For those born before July, 1984, the period of no national vaccination program, Taiwanese women had a higher HBsAg positive rate than other Southeast Asian women (15.7% vs. 8.4%), but for women born after that day and before June 1986, the period of vaccination for high risk newborns, the HBsAg positive rates found to be slightly lower for Taiwanese women than for other Southeast Asian women (11.4% vs. 12.3%) and the difference was more significant (3.1% vs. 28.6%) after June 1986, the period of vaccination for all newborns. While the HBeAg(+)/HBsAg(+) ratios decreased with age in both groups, they were consistently higher in women from other Southeast Asian countries than in women born in Taiwan after age 20.

ACCESSION #

51489028

 

Related Articles

• In this Issue.  // Kidney International;Feb2010, Vol. 77 Issue 3, p169 

  The article discusses various reports published within the issue, including "Lithium and Renal Failure Revisited," by Bendz et al, "Hepatitis B Vaccine," by Surquin et al and "Aging and Proteinuria in Mice," by Tsaih et al.

• The life-saving shot. Highfield, Roger // New Scientist;8/8/2009, Vol. 203 Issue 2720, p23 

  The article discusses the efficacy of vaccination in preventing deaths from hepatitis B and liver cancer. In China, a drop in prevalence of around 15%to fewer than 1% has been reported since the introduction of national vaccination programmes. However, the incidence of liver cancer in Taiwan...

• Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders. Visvanathan, Kumar; Dusheiko, Geoff; Giles, Michelle; Wong, May-Ling; Nghi Phung; Walker, Susan; Le, Suong; Gee Lim, Seng; Gane, Ed; Ngu, Meng; Hardikar, Winita; Cowie, Ben; Bowden, Scott; Strasser, Simone; Levy, Miriam; Sasaduesz, Joe // Gut;Feb2016, Vol. 65 Issue 2, p340 

  Hepatitis B during pregnancy presents unique management issues for both the mother and fetus. These include the lack of a current cohesive strategy for treatment and follow-up of mothers and their babies; the uncertain risk of postpartum HBV flares; the lack of randomised trial data on the...

• Schedules for hepatitis B vaccination of risk groups: balancing immunogenicity and compliance. Van Herck, K.; Leuridan, E.; Van Damme, P. // Sexually Transmitted Infections;Oct2007, Vol. 83 Issue 6, p426 

  Introduction: Vaccination is an important tool in hepatitis B prevention. However, several vaccine doses are required to induce long-term protection. Several at-risk groups have difficulties in adhering to the standard vaccination schedule. Objectives: This paper aims to review the use of...

• HB-Vax II.  // Royal Society of Medicine: Medicines;2002, p278 

  The article presents information on HB-Vax II, a proprietary, prescription-only preparation of hepatitis B vaccine. It can be used to give protection from hepatitis B in people at risk, and is available in a form for injection.

• Impact of universal preadolescent vaccination against hepatitis B on antenatal seroprevalence of hepatitis B markers in British Columbia women. Dawar, Meenakshi; Patrick, David M.; Bigham, Mark; Cook, Darrel; Krajden, Mel; Ng, Helen // CMAJ: Canadian Medical Association Journal;3/18/2003, Vol. 168 Issue 6, p703 

  Abstract COUNTRIES WITH A LOW RISK OF HEPATITIS B (HB) lack data on the effectiveness of universal HB vaccination programs for children. British Columbia began a program in 1992, offering HB vaccination to 11 year olds. We conducted an anonymous, unlinked serologic survey 7 years later,...

• Hepatitis Transmission in a Dental Office. Feferman, Irv // Ontario Dentist;Sep2007, Vol. 84 Issue 7, p18 

  The article examines a case of patient-to- patient transmission of hepatitis B (HBV) in a dental setting. The case underlines the need for vigilant infection control measures and significant universal immunization of health care workers. It will be interesting to know if the virus continues to...

• Combating Hepatitis B: The Tripura Model. Bhaumik, Pradip; Choudhury, Ajit Ranjan; Sinha, Priyabrata // Euroasian Journal of Hepato-Gastroenterology;Jul-Dec2011, Vol. 1 Issue 2, p39 

  Although hepatitis B is a major public health problem globally, mass vaccination against this virus is yet to be implemented in many countries of the world, including in India, which happens to be one of the most populous nations in the globe. Hepatitis Foundation of Tripura has become a role...

• Failure of Hepatitis B Immunization in Liver Transplant Recipients: Results of a Prospective Trial. Carey, William; Pimentel, Ronnie; Westveer, Mary Kay; Vogt, David; Broughan, Thomas // American Journal of Gastroenterology;Dec1990, Vol. 85 Issue 12, p1590 

  Twenty patients with advanced liver disease, in need of transplantation, were given three injections of 20 µg and three injections of 40 µg hepatitis B vaccine to see if an antibody response could be obtained. Only 20% of patients developed measurable anti-HBs. One who failed to develop...

Read the Article